Cost burden of post-transplant lymphoproliferative disease following kidney transplants in Medicare-eligible patients by survival status.
Sign Up to like & getrecommendations! Published in 2021 at "Journal of medical economics"
DOI: 10.1080/13696998.2021.1915793
Abstract: CONCLUSIONS PTLD represents a considerable HRU and cost burden following kidney transplant, and the burden is most pronounced in patients who die within 6 months. read more here.
Keywords: following kidney; burden; burden post; cost burden ... See more keywords